Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Stock
Equities
6990
CNE1000062J1
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
165 HKD | +2.48% | -1.96% | +60.35% |
Sales 2024 * | 1.16B 161M 1.26B | Sales 2025 * | 1.52B 211M 1.65B | Capitalization | 33.43B 4.63B 36.18B |
---|---|---|---|---|---|
Net income 2024 * | -550M -76.14M -595M | Net income 2025 * | -603M -83.48M -653M | EV / Sales 2024 * | 28.3 x |
Net cash position 2024 * | 575M 79.57M 622M | Net cash position 2025 * | 774M 107M 837M | EV / Sales 2025 * | 21.4 x |
P/E ratio 2024 * |
-58
x | P/E ratio 2025 * |
-53.1
x | Employees | 1,446 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.25% |
1 day | +2.48% | ||
1 week | -1.96% | ||
Current month | -1.96% | ||
1 month | +19.31% | ||
3 months | +93.89% | ||
6 months | +92.53% | ||
Current year | +60.35% |
Managers | Title | Age | Since |
---|---|---|---|
Jun You Ge
CEO | Chief Executive Officer | 51 | 21-02-07 |
Ze Jian Zhou
DFI | Director of Finance/CFO | 41 | 22-02-24 |
Xiang Yang Tan
CTO | Chief Tech/Sci/R&D Officer | 61 | 21-07-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ge Xin Liu
FOU | Founder | 73 | 16-11-21 |
Si Chuan Liu
BRD | Director/Board Member | 40 | 16-11-21 |
Hao Feng
BRD | Director/Board Member | 44 | 21-02-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 165 | +2.48% | 1,672,300 |
24-05-07 | 161 | -7.47% | 374,300 |
24-05-06 | 174 | +6.10% | 321,856 |
24-05-03 | 164 | -2.26% | 84,900 |
24-05-02 | 167.8 | -0.30% | 123,170 |
Delayed Quote Hong Kong S.E., May 08, 2024 at 04:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.35% | 4.51B | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- 6990 Stock